Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat

  • 15 Accesses

  • 2 Citations

Abstract

Alinidine, and eight derivatives, were synthesized and tested for their ability to antagonise the actions of the K+ channel opener cromakalim in rat thoracic aorta, and for their ability to induce bradycardia in rat isolated spontaneously beating right atria. Ring segments of rat thoracic aorta were suspended in organ baths to record isometric tension. Tissues were precontracted with K+(20 mM), and full concentration-relaxation curves constructed to cromakalim (0.01–30 μM) in the absence and presence of increasing concentrations of alinidine/derivative. The majority of the compounds tested caused rightward shifts in the cromakalim concentration-effect curves. Rat spontaneously beating right atria were suspended in organ baths to record rate of contraction. Addition of alinidine/derivative caused a concentration-dependent negative chronotropic response. In terms of structure-activity relationships, increasing the length of the N-allyl side-chain on the alinidine molecule (from 3 carbon (3C), to 5 C) resulted in a significant increase in the activity of the compounds as both bradycardic agents and cromakalim antagonists. The most potent compounds in both cases (bradycardic agent and cromakalim antagonist) had no double bond in the side chain. The results suggest that the carbon side-chain influences the activity of alinidine-related compounds both as cromakalim antagonists and as bradycardic agents. However, while similar structure-activity relationships appear to apply for both effects in some instances, there was no significant correlation between the two actions of the alinidine analogues. The results suggest that the ability of alinidine-derivatives to induce bradycardia or to block K+ channels opened by cromakalim can be differentiated on the basis of structure.

This is a preview of subscription content, log in to check access.

References

  1. Angus JA, Cocks TM, Satoh K (1986) α2-Adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol 88:767–777

  2. Bang L, Nielsen-Kudsk JE (1992) Smooth muscle relaxation and inhibition of responses to pinacidil and cromakalim induced by phentolamine in guinea-pig isolated trachea. Eur J Pharmacol 211: 235–241

  3. Beech DJ, Bolton TB (1989) Properties of the cromakalim-induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein. Br J Pharmacol 98:851–864

  4. Beech DJ, Zhang H, Nakao K, Bolton TB (1993a) K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle. Br J Pharmacol 110:573–582

  5. Beech DJ, Zhang H, Nakao K, Bolton TB (1993b) Single channel and whole cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein. Br J Pharmacol 110:583–590

  6. Boucher M, Chapuy E, Lefebvre MA, Mignot A, Duchene-Marullaz P (1989) Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block. Naunyn-Schmiedeberg's Arch Pharmacol 339:630–637

  7. Bouman LN, Duivenvoorden JJ, Opthof T, Treijtel BW (1984) Electrophysiological effects of alinidine on nodal and atrial fibres in the guinea-pig heart. J Pharmacol Exp Ther 229:551–556

  8. Bray KM, Quast U (1992) A specific binding site for K+ channel openers in rat aorta. J Biol Chem 267:11689–11692

  9. Carl A, Bowen S, Gelband CH, Sander KM, Hume JR (1992) Cromakalim and lemakalim activate Ca++-dependent K+ channels in canine colon. Pflügers Arch 421:67–76

  10. Challinor JL, McPherson GA (1992) Comparison of the K+ channel block and bradycardic actions of a series of alinidine analogues. Clin Exp Pharm Physiol 21[Suppl]:12

  11. Challinor JL, McPherson GA (1993) Evidence that imidazol(id)ine- and sulphonylurea-based antagonists of cromakalim act at different sites in the rat thoracic aorta. Clin Exp Pharm Physiol 20:467–475

  12. Chopra LC, Twort CHC, Ward JPT (1992) Direct action of BRL 38227 and glibenclamide on intracellular calcium stores in cultured airway smooth muscle of rabbit. Br J Pharmacol 105:259–260

  13. Dennis PD, Vaughan Williams EM (1986) Further studies of alinidine induced bradycardia in the presence of caesium. Cardiovasc Res 20:375–378

  14. Escande D, Cavero I (1992) K+ channel openers and ‘natural’ cardioprotection. Trends Pharmacol Sci 13:269–270

  15. Edwards G, Henshaw M, Miller M, Weston AH (1991) Comparison of the effects of several potassium channel openers on rat bladder and rat portal vein in vitro. Br J Pharmacol 102:679–686

  16. Eltze M (1989) Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP49356 in guinea-pig pulmonary artery. Eur J Pharmacol 165:231–239

  17. Good DM, Clapham JC, Hamilton TC (1992) Effects of BRL 38227 on neurally-mediated responses in the guinea-pig isolated bronchus. Br J Pharmacol 105:933–940

  18. Hageman GR, Neely BH, Urthaler F, James TN (1985) Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node and AV junction. Am J Physiol 248:H324-H330

  19. Hamada E, Takikawa R, Ito H, Iguchi M, Terano A, Sugimoto T, Kurachi Y (1990) Glibenclamide specifically blocks ATP-sensitive K+ channel current in atrial myocytes of guinea-pig heart. Jpn J Pharmacol 54:473–477

  20. Heginbotham L, McKinnon R (1992) The aromatic binding site for tetraethylammonium ion on potassium channels. Neuron 8: 483–491

  21. Jenkinson DH (1991) How we describe competitive antagonists: three questions of usage. Trends Pharmacol Sci 12:53–54

  22. Jonas JC, Plant TD, Henquin JC (1992) Imidazoline antagonists of α2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic β-cells. Br J Pharmacol 107:8–14

  23. Kenakin TP (1987) Pharmacologic analysis of drug-receptor interaction. Raven Press, New York

  24. Kobinger W, Lillie C, Pichler L (1979) N-allyl derivative of clonidine, a substance with specific bradycardic action at a cardiac site. Naunyn Schmiedeberg's Arch Pharmacol 306:255–262

  25. Lebrun P, Fang ZY, Antoine MH, Herchuelz A, Hermann M, Berkenboom G, Fontaine J (1990) Hypoglycaemic sulphonylureas antagonise the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta. Pharmacology 41:36–48

  26. Lillie C, Kobinger W (1983) Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions. Eur J Pharmacol 87:25–33

  27. Lillie C, Kobinger W (1983) Actions of alinidine and AQ-A 39 on rate and contractility of guinea-pig atria during β-adrenoceptor stimulation. J Cardiovasc Pharmacol 5:1048–1051

  28. Longmore J, Newgreen DT, Weston AH (1990) Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein. Eur J Pharmacol 190:75–84

  29. McHarg AD, Southerton JS, Weston AH (1990) A comparison of the actions of cromakalim and nifedipine on rabbit isolated mesenteric artery. Eur J Pharmacol 185:137–146

  30. McPherson GA (1993) Current trends in the study of potassium channel openers. Gen Pharmacol 24:275–281

  31. McPherson GA, Angus JA (1989) Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromakalim. Br J Pharmacol 97:941–949

  32. McPherson GA, Angus JA (1990) Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol 100:201–206

  33. Millar JS, Vaughan-Williams EM (1983) Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs. Br J Pharmacol 78:701–709

  34. Murray MA, Boyle JP, Small RC (1989) Cromakalim-induced relaxation of guinea-pig isolated trachealis: antagonism by glibenclamide and by phentolamine. Br J Pharmacol 98:865–874

  35. Newgreen DT, Longmore J, Weston AH (1990) The effect of glibenclamide on the action of cromakalim, diazoxide and minoxidil sulphate on rat aorta. Br J Pharmacol 96 [Suppl]:116P

  36. Noack T, Deitmer P, Edwards G, Weston AH (1992a) Characterization of potassium current modulated by BRL 38227 in rat portal vein. Br J Pharmacol 106:717–726

  37. Noack T, Edwards G, Deitmer P, Weston AH (1992b) Potassium channel modulation by ATP depletion; a comparison with the effects of levcromakalim (BRL38227). Br J Pharmacol 107:945–955

  38. Noma A (1983) ATP-regulated K+ channels in cardiac muscle. Nature 305:147–148

  39. Plant TD, Henquin JC (1990) Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic β-cells. Br J Pharmacol 101:115–120

  40. Russell SN, Smirnov SV, Aaronson PI (1992) Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery. Br J Pharmacol 105:549–556

  41. Satoh H, Hashimoto K (1986) Electrophysiological study of alinidine in voltage clamped rabbit sinoatrial node cells. Eur J Pharmacol 121:211–219

  42. Schwietert R, Wilhelm D, Wilffert B, Van Zwieten PA (1992) The effect of some alpha-adrenoceptor. antagonists on spontaneous myogenic activity in rat portal vein and the putative involvement of ATP-sensitive K+ channels. Eur J Pharmacol 211:87–95

  43. Siegl PKS, Wenger HC, Sweet CS (1984) Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anaesthetized dog. J Cardiovasc Pharmacol 6:565–574

  44. Stähle H, Pook K-H (1971) Synthesis in the 2-amino-imidazoline series. Liebigs Ann Chem 751:159–167

  45. Stahle H, Daniel H (1980) Chemistry, pharmacology and structure-activity with a new type of imidazolidines exerting a specific bradycardic action at a cardiac site. J Med Chem 23:1217–1222

  46. Standen NB, Quayle JM, Davis S, NW, Brayden JE, Huang Y, Nelson MT (1989) Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245:177–180

  47. Streller I, Walland A (1990) Anti-ischaemic effects of alinidine in paced isolated rat hearts. Basic Res Cardiol 85:71–77

  48. Uprichard ACG, Chi L, Lynch JJ, Driscoll EM, Frye JW, Lucchesi BR (1989) Alinidine reduces the incidence of ischaemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing. J Cardiovasc Pharmacol 14: 475–482

  49. Weston AH, Longmore J, Newgreen DT, Edwards G, Bray KM, Duty S (1990) The K+ channel openers: A new class of vasorelaxants. Blood Vessels 27:306–313

  50. Wilson C, Coldwell MC, Howlett DR, Cooper SM, Hamilton TC (1988) Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Eur J Pharmacol 152:331–339

Download references

Author information

Additional information

Correspondence to: G. A. McPherson at the above address

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Challinor-Rogers, J.L., Hay, T.K.C. & McPherson, G.A. Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 350, 158–166 (1994). https://doi.org/10.1007/BF00241091

Download citation

Key words

  • Alinidine
  • Bradycardia
  • Cromakalim
  • Imidazolines
  • K+ channels
  • K+ channel antagonists
  • Rat thoracic aorta
  • Rat spontaneously beating right atria